FGF-2 treatment of melanoma cells resulted in the reduction in syndecan-4 expression and downregulation of FAK Y397-phosphorylation thus decreasing cell attachment on FN and promoting their migration [47]. This evidence concerns the gene FGF2 and melanoma.